30 Nov , 2021 By : monika singh
Covid-19 vaccine was not mandatory, but voluntary, the Centre has said in a submission in the Supreme Court on Monday. On its part, SC said that it would examine any vaccine mandate issued by the executive, if challenged on the ground that it violated personal liberty guaranteed to all citizens under the Constitution.
The court was reacting to advocate Prashant Bhushan's submission that state governments were linking vaccination to travel, jobs et al. The Union health ministry said that only 2,116 adverse events following immunisation, including deaths, were reported from across the country.
The ministry said that all clinical data that could be shared have been placed in public domain and it was not possible to share any more due to privacy concerns. The Centre's response followed a court notice. The affidavit opposed any move to force the government to part with more data. It claimed that adverse effects were being monitored and reviewed.
"The percentage of such effects having serious/severe effects (including deaths) in case of covidshield and covaxin was less than 0.01 %, the government claimed." The 2,116 cases were reported from 1,193,844,741 doses of vaccines administered so far. "This again is in the caveat that any such serious/severe effect including death cannot be attributed to vaccination."
The government also denied that the vaccine was mandatory. "It is not linked to any benefits or services." However, people are being encouraged to vaccinate themselves as any individual's health may adversely impact the entire society, it said. No indemnity has been granted to any company manufacturing the drug. The vaccines have been approved by expert committees, including domain experts, after considering information from manufacturers regarding their efficacy, it said. Post vaccination information is already in the public domain and authorities are continuously monitoring and examining the data.
The clinical data generated by trials reside with the sponsor and the data can be submitted to regulatory authorities for obtaining licenses. This data can be verified but there is no provision under which the regulatory authority can ask for the full data on clinical trials, the government said.
The court led by Justice L Nageswar Rao will now hear the case again on December 13.
0 Comment